UCARTCS1

Overview

UCARTCS1 is an allogeneic (donor-derived) CAR T-cell therapy being developed for multiple myeloma patients.

SparkCures ID 338
Developed By Cellectis
Generic Name UCARTCS1
Treatment Classifications
Treatment Targets

Clinical Trials

Resources